Medical Terminologies for Interoperable eHealth Systems

The second webinar in our Hospitals on FHIR series on Implementing the EU Lab Report in your Hospital, delivered in partnership with the XiA Project, is coming up next week — don’t miss it! In this free 30-minute session, we’ll explore the foundations of semantic interoperability and why medical terminologies are critical to making the EHDS a reality. Roberta Gazzarata, PhD. (HL7 Europe) will guide us through: 🔹 The broader context: EHDS & the EU Lab Report 🔹 What semantic interoperability means in practice 🔹 An introduction to key medical terminologies 🔹 Real-world examples from the EU Lab Report 🔹 Key implications for hospital implementation Join us! 📅 Medical Terminologies – Foundations for Semantic Interoperability 🗓 26 March 2026 | 15:00 CET 🔗 https://lnkd.in/dpHJ9Hr6 Hospitals on FHIR continues to support hospitals and national stakeholders in understanding and implementing HL7 FHIR within the EHDS framework. #EHDS #FHIR  #HospitalsOnFHIR  #Interoperability #DigitalHealth #HL7Europe Stefano Dalmiani Rhonda Facile Luc Chatty Catherine E Chronaki, FHL7, FIAHSI, MBA Giorgio Cangioli Jan-Eric SLOT

Join us to understand the relevance of "I understand what I receive" and "I can use it safely", for Laboratories but not only!

Don't miss the 2nd installment of the Hospitals on FHIR series on Implementing the EU Lab Report in your Hospital. This time we focus on Medical Terminologies and the need for semantic interoperability. Delivered by Dr. Roberta Gazzarata (HL7 EU), it's free, and only 30 minutes in duration. We think it's time well spent! Join Us!

We are pleased to announce the publication of the HIMSS D-A-CH white paper “Interoperability in hospitals in view of the European Health Data Space”. This document highlights the key role of interoperability in European hospitals within the context of the European Health Data Space (EHDS) regulation and illustrates its concrete impact through several real-world use cases. 🔍 A section of the white paper is dedicated to Centre Hospitalier de Gonesse (France), focusing on the implementation of the Philips Capsule Medical Device Information Platform (MDIP). MDIP enables the hospital to connect medical devices to the hospital information system, standardize and secure device data, and simplify the IT architecture. For clinical teams, this results in better real-time data availability, time savings, and improved decision support, contributing to patient safety and continuity of care. 👉 Read the White Paper: https://lnkd.in/gUHiityB

Following on from my earlier post: https://lnkd.in/eNW7pSiG The section titled “Diagnostic Pathway Support” sets out how I’ve been tackling the first chasm. The approach builds primarily on Yorkshire, Welsh and EU Core standards, together with IHE and HL7. Notably, this has led me to positions closely aligned with those adopted in Switzerland (https://lnkd.in/emGdd4rR ) and likely consistent with France (https://lnkd.in/er2tMGU8 ) and other countries advancing similar interoperability frameworks. I’ve also drawn on elements from NHS England and IHE UK Radiology (National Imaging Registry), which is where the original linkage to the French and Swiss approaches emerged. Traces of the second chasm are visible at the edges of the diagram. This prompts a broader question: are we dealing with an organisational issue — Conway’s Law at play? I don’t see this work as North West–specific; the patterns and solutions feel far more generalisable. It seems the core issue may be the absence of a dedicated England/UK body to coordinate diagnostic pathway support. Is that role meant to sit with IHE UK? And if so, should one of the UK NHS organisations (England, Wales, NI or Scotland) — or the Department of Health — be formally funding and backing IHE UK to fulfil it?

#EHJCVI 📢 New #EACVI & @ASE360 Consensus Statement on Strain Echo🚨 Strain has moved from the research arena into everyday #echofirst clinical practice. A practical guide for clinical echocardiographers, with clear supporting evidence for its use ⏭️ https://lnkd.in/e79wgqiB

Excited to be contributing to the EBMT Annual Meeting 2026 in Madrid this week — both as session chair and presenter in the CAR-T oral session. I will be chairing Oral Session 13 | CAR-T, together with Igor Kos, and also presenting our work on risk dynamics after lisocabtagene maraleucel infusion. In this pooled analysis of 7 clinical trials, we aimed to address a very practical question in daily CAR-T care: 👉 What is the residual risk of CRS or neurological events from any given day after infusion? By quantifying day-by-day risk, we observed that: - The vast majority of events occur within the first 15 days - Residual risk decreases rapidly over time - Patients without prior events represent a lower-risk subgroup These findings may help support more individualized monitoring strategies and inform decisions around timing of discharge after CAR-T infusion, particularly as the field moves toward more flexible care models. 📍 Session: OS13 Oral Session 13 | CAR-T 🕒 Tuesday, March 24 | 14:30–15:45 (presentation at 15:24) 📍 Room N107 — Abstract #643 Looking forward to the discussion and to exchanging perspectives with colleagues across the field. #EBMT2026 #CART #CellTherapy #Hematology #ClinicalResearch

We’re excited to join our colleagues from CoverMyMeds, a McKesson company, at HIMSS Global Health Conference 2026 for this session focused on reducing fragmentation across the specialty care journey. Our shared mission is clear: expand specialty access and affordability through connected, data‑driven solutions that support providers, payers and biopharma partners, and ultimately help patients start therapy sooner. Join Ontada's Molly Brady, RN, Director of Customer Success at this Industry Solution Session to explore how coordinated workflows can help streamline specialty processes and accelerate time‑to‑therapy. #HIMSS26 #SpecialtyCare #Biopharma #TeamMcKesson

⭐ EAPCI Summit 2026 TAVI Symposium - Now available on demand ⭐ If you could not join us live, you can now watch the recording of “Designing a Lifetime of Care: TAVI decision-making in younger patients.” The session explores: 🔵 The evolving role of TAVI in younger patients 🔵 How the ESC/EACTS 2025 guidelines inform patient selection 🔵 Planning for durability, lifetime management, and future interventions Access the on-demand recording from EAPCI Summit 2026 https://bit.ly/4bvmBOL Product usage represented may not be approved or cleared in all markets.

This week we celebrate #healthcarescienceweek2026 A chance to recognise the incredible work of healthcare scientists across the UK who support patient care every day. From diagnostic testing and medical imaging to genomics and physiological science, healthcare scientists play a vital role in ensuring patients receive accurate diagnoses and effective treatment. Behind the scenes, their expertise underpins many of the critical decisions made across our healthcare system. At UKAS , we’re proud to support this work through accreditation, helping laboratories, diagnostic services and healthcare providers demonstrate competence, consistency and trust. Accreditation provides confidence that services are operating to internationally recognised standards, supporting quality, reliability and ultimately better outcomes for patients. Healthcare Science Week is a great opportunity to highlight the people, technology and standards that make high-quality healthcare possible. Thank you to all healthcare scientists and accredited organisations whose dedication helps maintain trust in vital healthcare services. #HealthcareScienceWeek #HealthcareScience #QualityInHealthcare #Accreditation #PatientSafety #UKAS #AHCS